Image source: Getty Images
In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week in a disappointing fashion. At the time of writing the benchmark index is down 1% to 6,034.4 points.
Four shares that have not let that hold them back today are listed below. Here's why they are pushing higher:
The Alcidion Group Ltd (ASX: ALC) share price has jumped almost 7% to 16 cents. This morning the healthcare technology company announced an enterprise agreement with NHS Lanarkshire for a five-year term. The agreement will see the health board deploy Alcidion's Patientrack electronic bedside monitoring system across its entire regional health network. The total value of the new contract is ~$1.5 million over five years.
The Bubs Australia Ltd (ASX: BUB) share price is up 3.5% to $1.01 despite there being no news out of the infant formula and baby food company. However, Bubs is likely to release its fourth quarter update next week. Investors may be snapping up shares on Friday in anticipation of a stellar update. Infant formula demand has been very strong during the pandemic and could have underpinned solid sales growth in the fourth quarter.
The IGO Ltd (ASX: IGO) share price has stormed 4.5% higher to $5.41. This follows a jump in the spot nickel price overnight. According to CommSec, the nickel price climbed 4.2% to US$13,650.75 a tonne. It was the best-performing base metal during overnight commodities trading.
The Next Science Ltd (ASX: NXS) share price has risen 2.5% to $1.37. This follows the release of the medical technology company's second quarter update on Thursday. Next Science's performance was negatively impacted during the quarter due to the shutdown of elective surgeries. As a result, it reported cash receipts of $1.9 million. However, management expects a rebound in revenues as surgeries recommence and wound care clinics reopen.
